Literature DB >> 7908437

X-ray structures of fragments from binding and nonbinding versions of a humanized anti-CD18 antibody: structural indications of the key role of VH residues 59 to 65.

C Eigenbrot1, T Gonzalez, J Mayeda, P Carter, W Werther, T Hotaling, J Fox, J Kessler.   

Abstract

X-ray crystal structures of fragments from two different humanized anti-CD18 antibodies are reported. The Fv fragment of the nonbinding version has been refined in space group C2 with a = 64.2 A, b = 61.3 A, c = 51.8 A, and beta = 99 degrees to an R-value of 18.0% at 1.9 A, and the Fab fragment of the tight-binding version has been refined in space group P3 with a = 101. A and c = 45.5 A to an R-value of 17.8% at 3.0 A resolution. The very large difference in their binding affinity (> 1000-fold) is attributed to large and local structural differences in the C-terminal part of CDR-H2, and from this we conclude there is direct contact between this region and antigen when they combine. X-ray structures of antibody-antigen complexes available in the literature have yet to show this part of CDR-H2 in contact with antigen, despite its hypervariable sequence. Implications of this result for antibody humanization are discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7908437     DOI: 10.1002/prot.340180107

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  8 in total

1.  Electrostatic properties of protein-protein complexes.

Authors:  Petras J Kundrotas; Emil Alexov
Journal:  Biophys J       Date:  2006-06-16       Impact factor: 4.033

2.  Structure of the Fab fragment of F105, a broadly reactive anti-human immunodeficiency virus (HIV) antibody that recognizes the CD4 binding site of HIV type 1 gp120.

Authors:  Royce A Wilkinson; Chayne Piscitelli; Martin Teintze; Lisa A Cavacini; Marshall R Posner; C Martin Lawrence
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

3.  Expression studies of catalytic antibodies.

Authors:  H D Ulrich; P A Patten; P L Yang; F E Romesberg; P G Schultz
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

4.  Development of anti-p185HER2 immunoliposomes for cancer therapy.

Authors:  J W Park; K Hong; P Carter; H Asgari; L Y Guo; G A Keller; C Wirth; R Shalaby; C Kotts; W I Wood
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

5.  Enhancement and destruction of antibody function by somatic mutation: unequal occurrence is controlled by V gene combinatorial associations.

Authors:  C Chen; V A Roberts; S Stevens; M Brown; M P Stenzel-Poore; M B Rittenberg
Journal:  EMBO J       Date:  1995-06-15       Impact factor: 11.598

6.  Transitions of CDR-L3 Loop Canonical Cluster Conformations on the Micro-to-Millisecond Timescale.

Authors:  Monica L Fernández-Quintero; Barbara A Math; Johannes R Loeffler; Klaus R Liedl
Journal:  Front Immunol       Date:  2019-11-19       Impact factor: 7.561

7.  The structural repertoire of the human V kappa domain.

Authors:  I M Tomlinson; J P Cox; E Gherardi; A M Lesk; C Chothia
Journal:  EMBO J       Date:  1995-09-15       Impact factor: 11.598

8.  QSAR Implementation for HIC Retention Time Prediction of mAbs Using Fab Structure: A Comparison between Structural Representations.

Authors:  Micael Karlberg; João Victor de Souza; Lanyu Fan; Arathi Kizhedath; Agnieszka K Bronowska; Jarka Glassey
Journal:  Int J Mol Sci       Date:  2020-10-28       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.